Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

De Luca L et al. - Abciximab does not seem to have any impact on the extent of in-segment LLL in diabetic patients undergoing an elective PES implantation.